153 related articles for article (PubMed ID: 15173085)
1. Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma.
Beger C; Ramadani M; Meyer S; Leder G; Krüger M; Welte K; Gansauge F; Beger HG
Clin Cancer Res; 2004 Jun; 10(11):3780-7. PubMed ID: 15173085
[TBL] [Abstract][Full Text] [Related]
2. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of BRCA1, BRCA2 and Hmsh2 mRNA expression in colorectal Lieberkühnien adenocarcinomas and matched normal mucosa: relationship with cellular proliferation.
Le Corre L; Vissac-Sabatier C; Chalabi N; Bignon YJ; Daver A; Chassevent A; Bernard-Gallon DJ
Anticancer Res; 2005; 25(3B):2009-16. PubMed ID: 16158938
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.
Logsdon CD; Simeone DM; Binkley C; Arumugam T; Greenson JK; Giordano TJ; Misek DE; Kuick R; Hanash S
Cancer Res; 2003 May; 63(10):2649-57. PubMed ID: 12750293
[TBL] [Abstract][Full Text] [Related]
5. Expression of BRCA1 and BRCA2 in male breast cancers and gynecomastias.
Bernard-Gallon DJ; Déchelotte PJ; Le Corre L; Vissac-Sabatier C; Favy DA; Cravello L; De Latour MP; Bignon YJ
Anticancer Res; 2003; 23(1B):661-7. PubMed ID: 12680164
[TBL] [Abstract][Full Text] [Related]
6. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
7. Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.
Aaltonen K; Blomqvist C; Amini RM; Eerola H; Aittomäki K; Heikkilä P; Nevanlinna H
Clin Cancer Res; 2008 Apr; 14(7):1976-83. PubMed ID: 18381935
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
Chan KY; Ozçelik H; Cheung AN; Ngan HY; Khoo US
Cancer Res; 2002 Jul; 62(14):4151-6. PubMed ID: 12124354
[TBL] [Abstract][Full Text] [Related]
9. Differential gene expression in patients genetically predisposed to pancreatic cancer.
Zervos EE; Tanner SM; Osborne DA; Bloomston M; Rosemurgy AS; Ellison EC; Melvin WS; de la Chapelle A
J Surg Res; 2006 Oct; 135(2):317-22. PubMed ID: 16815451
[TBL] [Abstract][Full Text] [Related]
10. Differential expressions of BRCA1 and BRCA2 in infantile gynecomastia.
Bernard-Gallon DJ; Dechelotte PJ; Le Corre L; Chalabi N; Vissac-Sabatier C; Bignon YJ
Anticancer Res; 2004; 24(1):321-4. PubMed ID: 15015615
[TBL] [Abstract][Full Text] [Related]
11. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia.
Martignoni ME; Kunze P; Hildebrandt W; Künzli B; Berberat P; Giese T; Klöters O; Hammer J; Büchler MW; Giese NA; Friess H
Clin Cancer Res; 2005 Aug; 11(16):5802-8. PubMed ID: 16115919
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 gene expression in breast cancer: a correlative study between real-time RT-PCR and immunohistochemistry.
Al-Mulla F; Abdulrahman M; Varadharaj G; Akhter N; Anim JT
J Histochem Cytochem; 2005 May; 53(5):621-9. PubMed ID: 15872055
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma.
Crnogorac-Jurcevic T; Gangeswaran R; Bhakta V; Capurso G; Lattimore S; Akada M; Sunamura M; Prime W; Campbell F; Brentnall TA; Costello E; Neoptolemos J; Lemoine NR
Gastroenterology; 2005 Nov; 129(5):1454-63. PubMed ID: 16285947
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of BRCA-associated breast cancer: a summary of evidence.
Bordeleau L; Panchal S; Goodwin P
Breast Cancer Res Treat; 2010 Jan; 119(1):13-24. PubMed ID: 19789974
[TBL] [Abstract][Full Text] [Related]
16. Loss of nuclear BRCA1 localization in breast carcinoma is age dependent.
Bogdani M; Teugels E; De Grève J; Bourgain C; Neyns B; Pipeleers-Marichal M
Virchows Arch; 2002 Mar; 440(3):274-9. PubMed ID: 11889597
[TBL] [Abstract][Full Text] [Related]
17. Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines.
Favy DA; Lafarge S; Rio P; Vissac C; Bignon YJ; Bernard-Gallon D
Biochem Biophys Res Commun; 2000 Jul; 274(1):73-8. PubMed ID: 10903898
[TBL] [Abstract][Full Text] [Related]
18. Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers.
De Brakeleer S; Bogdani M; De Grève J; Decock J; Sermijn E; Bonduelle M; Goelen G; Teugels E
Mutat Res; 2007 Jun; 619(1-2):104-12. PubMed ID: 17445839
[TBL] [Abstract][Full Text] [Related]
19. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
[TBL] [Abstract][Full Text] [Related]
20. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
